Citation Impact
Citing Papers
Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients
2011
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
2017
Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals
2010 StandoutNobel
Exploiting the Mutanome for Tumor Vaccination
2012
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3 + CD25 + CD4 + regulatory T cells
2005 StandoutNobel
The Outcomes of First Reoperation for Locoregionally Recurrent/Persistent Papillary Thyroid Carcinoma in Patients Who Initially Underwent Total Thyroidectomy and Remnant Ablation
2011
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Thyroid Lobectomy for Papillary Thyroid Cancer: Long‐term Follow‐up Study of 1,088 Cases
2013
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
Vitiligo-Like Depigmentation in Patients With Stage III-IV Melanoma Receiving Immunotherapy and Its Association With Survival: A Systematic Review and Meta-Analysis
2015
Combinatorial Cancer Immunotherapy
2006
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Thyroid cancer
2016 Standout
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
About human tumor antigens to be used in immunotherapy
2008
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
Management and Outcome of Recurrent Well-Differentiated Thyroid Carcinoma
2004
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma
2000
Efficacy of Nodal Dissection for Treatment of Persistent/Recurrent Papillary Thyroid Cancer
2008
Imaging in the era of molecular oncology
2008 StandoutNature
Mature Dendritic Cells Induce Tumor-Specific Type 1 Regulatory T Cells
2005
The Human T Cell Response to Melanoma Antigens
2006
Cost-effective Management of Low-Risk Papillary Thyroid Carcinoma
2007
Cancer immunotherapy via dendritic cells
2012 Standout
Interferons Induce CXCR3-cognate Chemokine Production by Human Metastatic Melanoma
2010
Trial watch
2013
Long-Term Outcome of Patients With Differentiated Thyroid Carcinoma: Effect of Therapy
2000
A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period
2004
Contralateral Papillary Thyroid Cancer is Frequent at Completion Thyroidectomy with No Difference in Low- and High-Risk Patients
2001
Effects of granulocyte‐macrophage colony‐stimulating factor and foreign helper protein as immunologic adjuvants on the T‐cell response to vaccination with tyrosinase peptides
2003
Neck recurrence from thyroid carcinoma: serum thyroglobulin and high‐dose total body scan are not reliable criteria for cure after radioiodine treatment
2005
Towards patient‐specific tumor antigen selection for vaccination
2002
AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States
2004
An Overview of the Management of Papillary and Follicular Thyroid Carcinoma
1999
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
2005 StandoutNobel
Induction of neutralising antibodies restricts the use of human granulocyte/macrophage colony stimulating factor for vaccine studies in rhesus macaques
2004 StandoutNobel
Prognostic Indicators of Outcomes in Patients with Distant Metastases from Differentiated Thyroid Carcinoma
2003
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Regulatory T cells, tumour immunity and immunotherapy
2006 Standout
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity
2019
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Strategies of Tumor Immune Evasion
2005
Extent of Thyroidectomy Is Not a Major Determinant of Survival in Low- or High-Risk Papillary Thyroid Cancer
2004
Prognostic Factors Associated with the Survival of Patients Developing Loco-Regional Recurrences of Differentiated Thyroid Carcinomas
2004
Preventable reoperations for persistent and recurrent papillary thyroid carcinoma
2004
Tumor‐reactive CD8+ T‐cell responses after vaccination with NY‐ESO‐1 peptide, CpG 7909 and Montanide® ISA‐51: association with survival
2009
Regulatory T cells in cancer immunotherapy
2016 StandoutNobel
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Use of Radioactive Iodine for Thyroid Remnant Ablation in Well-Differentiated Thyroid Carcinoma to Replace Thyroid Reoperation
1998
Autologous tumor vaccines processed to express ?-gal epitopes: a practical approach to immunotherapy in cancer
2004
Central Compartment Reoperation for Recurrent/Persistent Differentiated Thyroid Cancer: Patterns of Recurrence, Morbidity, and Prediction of Postoperative Hypocalcemia
2010
Cancer immunotherapy comes of age
2011 StandoutNature
Paradoxical roles of the immune system during cancer development
2006 Standout
Extent of Surgery Affects Survival for Papillary Thyroid Cancer
2007 Standout
Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity
2010
Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy
1996
Regulatory T cells in tumor immunity
2010 StandoutNobel
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Immunity to Melanoma Antigens: From Self‐Tolerance to Immunotherapy
2006
Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma
2010 StandoutNobel
Overall and cause‐specific survival for patients undergoing lobectomy, near‐total, or total thyroidectomy for differentiated thyroid cancer
2010
A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
2013
Cancer as an evolutionary and ecological process
2006 Standout
Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma
1998
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
T-cell responses of vaccinated cancer patients
2003
Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy
2006
The Effectiveness of Radioactive Iodine for Treatment of Low-Risk Thyroid Cancer: A Systematic Analysis of the Peer-Reviewed Literature from 1966 to April 2008
2010
Manipulating dendritic cell biology for the active immunotherapy of cancer
2004
Recent Developments in Cancer Vaccines
2011
Thyroid Cancer Nodal Metastases: Biologic Significance and Therapeutic Considerations
1996
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
2012 StandoutNobel
Local Administration of PF-3512676 CpG-B Instigates Tumor-Specific CD8+ T-Cell Reactivity in Melanoma Patients
2008
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Innovations and Challenges in Renal Cell Carcinoma: Summary Statement from the Second Cambridge Conference
2007 StandoutNobel
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/− Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN-α2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696
2009
Cancer Genome Landscapes
2013 StandoutScience
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting
2007
HUMAN T CELL RESPONSES AGAINST MELANOMA
2005
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Combination of Radioiodine (131I) and Probe-Guided Surgery for Persistent or Recurrent Thyroid Carcinoma
1998
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Neoantigens in cancer immunotherapy
2015 StandoutScience
Rational approaches to human cancer immunotherapy
2003
Thyroid carcinoma
2003 Standout
The α‐gal epitope and the anti‐Gal antibody in xenotransplantation and in cancer immunotherapy
2005
Works of David Teates being referenced
Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic Cells
2003
Recurrent Thyroid Cancer Role of Surgery Versus Radioactive Iodine (I131)
1994
Total Thyroidectomy Does Not Enhance Disease Control or Survival Even in High-Risk Patients With Differentiated Thyroid Cancer
1998
Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients
2001